Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

116.18 +1.78 (+1.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,118,213
Open 115.02
Bid (Size) 115.72 (1)
Ask (Size) 116.50 (2)
Prev. Close 114.40
Today's Range 114.52 - 116.87
52wk Range 66.89 - 134.76
Shares Outstanding 96,748,901
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
 
Via Benzinga
2 All-Weather Stocks to Buy Without Hesitation Right Now
Despite near-term economic clouds, long-term investors can still find compelling buying opportunities. 
Via The Motley Fool

Performance

YTD
+1.26%
+1.26%
1 Month
-4.17%
-4.17%
3 Month
+1.26%
+1.26%
6 Month
+36.71%
+36.71%
1 Year
-12.58%
-12.58%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
Via Benzinga
Analyst Ratings for DexCom
Via Benzinga
Where Will DexCom Be in 1 Year?
Via The Motley Fool
Price Over Earnings Overview: DexCom
Via Benzinga
Elliott Wave Technical Analysis: DexCom Inc.
Via Talk Markets
Nasdaq Bear Market: 2 Growth Stocks to Buy That Keep Bucking the Trend
Via The Motley Fool
Have $1,000? 2 Stock-Split Companies to Add to Your Buy Basket Right Now.
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,900 Today
Via Benzinga
DexCom Comments on SVB Relationship
From DexCom, Inc.
Via Business Wire
(DXCM) - Analyzing DexCom's Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
Via Benzinga
Stock Market Tumbles Amid SVB Financial Collapse, 'Faster' Powell: Weekly Review
Via Investor's Business Daily
2 Top Stocks to Buy in March and Hold Forever
Via The Motley Fool
Want to Get Richer? 2 Top Stocks to Buy Now and Hold Forever
Via The Motley Fool
5 Stocks That Powered Nasdaq ETF Last Week
Via Talk Markets
Dexcom Pummeled On A New FDA Clearance For Key Rival Abbott Laboratories
Via Investor's Business Daily
Stock Market Rally Rebounds Despite Rising Yields; Salesforce, Tesla In Focus: Weekly Review
Via Investor's Business Daily
1 High-Flying Growth Stock With 19% Upside, According to Wall Street
Via The Motley Fool
Dexcom Nears Breakout On A Surprise Medicare Decision For Its Devices
Via Investor's Business Daily
Where to Invest $1,000 in a 2023 Nasdaq Bear Market
Via The Motley Fool
Should Abbott and DexCom Investors Be Worried About Apple's Latest News?
Via The Motley Fool
What Do Sanofi And Dexcom See In DarioHealth That The Market Is Missing?
Via News Direct
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.